Drug Trial Radar · NCT00478101
Opioid Rotation Versus Combination for Chronic Uncontrolled Cancer Pain
Last checked: Nov 19, 2026Latest source record: Mar 13, 2008 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,006
Actual
Start
Feb 2006
Primary completion
Not stated
Study completion Apr 2007
Sponsor
- Lead sponsor
- Gachon University Gil Medical CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 24, 2007
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Supportive care
- Who can join
- All sexes, from 19 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
For cancer patients with inadequate pain relief, a switch to an alternative opioid is the preferred option for symptomatic improvement. However, multiple opioids are often simultaneously administered for anecdotal reasons. The present study isdesigned to assess the analgesic profiles of two different strategies in chronic cancer pain: the opioid rotation from oxycodone to transdermal fentanyl and the combination of oral oxycodone and transdermal fentanyl.
Conditions
- Advanced Solid Cancers
Interventions
oxycodone fentanylDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in pain score and treatment success
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.